Relacorilant 150 mg once daily (QD)
CORT125134-557
Phase 2 small_molecule active
Quick answer
Relacorilant 150 mg once daily (QD) for Ovarian Cancer is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active